Type 2 diabetes mellitus (T2DM) is often associated with obesity and subnormal serum testosterone (T) levels. Until 5 years ago there was no indication that men with type 1 diabetes mellitus (T1DM) had subnormal serum T. But recent studies indicate that about 10% of men with T1DM suffer from hypogonadism, as a rule aged men and men with obesity. While hypogonadal men with T2DM benefit from normalization of their serum T, this has not been investigated in men with T1DM. Nine men with T1DM, erectile dysfunction and hypogonadism (total testosterone ≤ 12 nmol/L) received testosterone replacement therapy (TRT). In seven men TRT was intermitted: one man with prostate malignancy and six men because of problems of reimbursement. Incidentally, this provided an opportunity to monitor the effects of withdrawal and of the reinstatement of TRT. In all men, glycemic control (serum glucose and HbA1c), weight, waist circumference, lipid profiles and erectile function improved upon TRT. The seven men whose TRT was intermitted showed a deterioration which improved again upon reinstatement of TRT. The data suggest that aging and obese men with T1DM might have subnormal T levels and that their glycemic control, lipid profiles and erectile function might benefit from TRT.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.3109/13685538.2015.1034687 | DOI Listing |
Diabetes Res Clin Pract
January 2025
Guang'an Men Hospital, China Academy of Chinese Medicine, No.5, beixiange, Xicheng District, Beijing, China. Electronic address:
Backgrounds: Chronic kidney disease (CKD) is a major complication of diabetes, which is rising among adolescents and young adults worldwide, but data on the trends of these diseases are sparse. This study examined the burden of CKD due to type 1 diabetes (CKD-T1D) and type 2 diabetes (CKD-T2D) among those aged 10-35 from 1990 to 2021 on global, regional, and national levels.
Methods: Using Global Burden of Disease 2021 data, joinpoint regression analysis and decomposition analysis were employed to identify significant changes in CKD-T1D and CKD-T2D trends, including incidence, prevalence, mortality, and disability-adjusted life years (DALYs).
J Clin Endocrinol Metab
December 2024
Susan B. Meister Child Health and Evaluation Research Center, University of Michigan Medical School, Ann Arbor, MI, USA.
Autoimmun Rev
December 2024
Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei 230032, Anhui, People's Republic of China; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Hefei 230032, Anhui, People's Republic of China. Electronic address:
J Int Med Res
October 2024
Department of Endocrinology, University Hospital of Farhat Hached Sousse, Sousse, Tunisia.
Objective: The aim of this study was to identify factors associated with severe diabetic ketoacidosis (DKA) at the onset of type 1 diabetes mellitus (T1DM) in adult patients.
Methods: We conducted a retrospective analysis over a 10-year period including adults newly diagnosed with T1DM. Eligible participants were diagnosed with DKA at the time of T1DM diagnosis.
Hormones (Athens)
October 2024
Endocrinology and Nutrition Department of Hospital de la Santa Creu i Sant Pau, Carrer de Sant Quintí 89, Barcelona, 08041, Spain.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!